SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEbiquity Regulatory News (EBQ)

Share Price Information for Ebiquity (EBQ)

Share Price is delayed by 15 minutes
Get Live Data
10.75    0.00 (0.00%)
Bid:
10.50
Ask:
11.00
Spread: 0.50 (4.762%)
Market Cap: £14.94m
EBQ Live PriceLast checked at - London Stock Exchange

Intraday Ebiquity Share Chart

Trading Update

22 Nov 2018 07:00

RNS Number : 1435I
Ebiquity PLC
22 November 2018
 

Ebiquity Plc

 

Trading Update

 

 

Ebiquity plc ("Ebiquity"), a leading independent marketing and media consultancy, provides a trading update in relation to the financial year to 31 December 2018.

 

At Group level, Ebiquity anticipates organic revenue growth of circa 2%. However, the previously reported slowdown in the Advertising Intelligence practice, coupled with continued underperformance of the US Digital Analytics practice (for which actions have been taken) and delays in closing recent Media practice opportunities in Germany will result in operating profit being materially below current market expectations. With today's announcement of the CMA's final clearance of the sale of the Advertising Intelligence business, the Group's net debt position will be materially improved following the receipt of sale proceeds now anticipated to be around the end of the year.

 

Despite the revenue delays in Germany and challenges in the US Digital Analytics practice, the Media, Analytics and Tech practices (being the retained business following the disposal of the Advertising Intelligence business) continue to make strong progress in most territories, with overall revenue growth in line with expectations at circa 8% with particularly encouraging performances in the UK & Ireland and French markets. Encouraging new business wins in H2 include a global multi-year assignment across VW Group and the appointment as a global analytics partner to Nestle. Overall however, at an operating profit level, continued investment in these practices will mean profits are anticipated being below expectations.

 

The Advertising Intelligence practice continued to underperform in the year, given the ongoing uncertainties around the proposed disposal. This lengthy process required a considerable amount of management time and attention. The completion of this transaction will simplify the Group allowing it to focus on growing its core Media, Analytics and Tech practices going forward.

 

22 November 2018

Enquiries:

 

Ebiquity plc

Michael Karg (CEO)

Kevin McNair (Interim CFO)

 

020 7650 9600

 

Instinctif Partners

Matthew Smallwood

Guy Scarborough

020 7457 2020

 

Numis Securities Limited

Nick Westlake (NOMAD)

Michael Wharton

 

020 7260 1000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTDDBDBIUDBGIB
Date   Source Headline
11th Mar 20152:16 pmRNSExercise of Share Options
26th Feb 20152:14 pmRNSAcquisition of Media Value
16th Feb 201512:45 pmRNSExercise of Share Options
13th Feb 20153:50 pmRNSAcquisition and issue of shares
6th Feb 201510:34 amRNSDirector/PDMR Shareholding
4th Feb 20155:00 pmRNSHolding(s) in Company
2nd Feb 20152:55 pmRNSHolding(s) in Company
28th Jan 20157:00 amRNSInterim Results
19th Jan 20158:45 amRNSExercise of Share Options
8th Jan 20154:28 pmRNSHolding(s) in Company
27th Nov 20147:00 amRNSExercise of Share Options
24th Nov 20143:00 pmRNSDirector Dealing
24th Nov 20142:59 pmRNSHolding(s) in Company
24th Nov 20142:55 pmRNSDirector Dealing and Exercise of Share Options
21st Nov 20147:00 amRNSAppointment of Non-Executive Directors
21st Nov 20147:00 amRNSTrading update
14th Nov 20143:22 pmRNSDirector Dealing
11th Nov 20149:10 amRNSDirector Dealing
10th Sep 201411:57 amRNSResult of AGM
6th Aug 20147:00 amRNSAnnual Report
31st Jul 20143:49 pmRNSHolding(s) in Company
16th Jul 20147:00 amRNSFinal Results
3rd Jul 20147:00 amRNSNew Debt Facility
13th Jun 20148:30 amRNSAppointment of MD, South East Asia
16th May 201411:33 amRNSAward of share options
8th May 20147:00 amRNSAcquisition
14th Apr 20147:00 amRNSAppointment of CEO, Americas
7th Apr 20147:00 amRNSPayment of deferred consideration
19th Mar 20147:00 amRNSChange of Registered Office
13th Mar 20143:05 pmRNSHolding(s) in Company
11th Mar 20145:32 pmRNSExercise of Share Options
7th Mar 20141:04 pmRNSExercise of Share Options
7th Mar 20147:00 amRNSDirectors' dealings and directorate changes
6th Mar 20147:00 amRNSDirectorate
3rd Mar 201412:02 pmRNSHolding(s) in Company
21st Feb 20149:32 amRNSHolding(s) in Company
20th Feb 20145:45 pmRNSHolding in Company / Issue of Equity
13th Feb 201411:00 amRNSHolding in Company / Issue of Equity
13th Feb 201410:24 amRNSHolding(s) in Company
12th Feb 201410:34 amRNSHolding(s) in Company
7th Feb 201412:50 pmRNSHolding(s) in Company
7th Feb 201412:10 pmRNSHolding(s) in Company
6th Feb 201412:02 pmRNSHolding(s) in Company
5th Feb 20144:49 pmRNSHolding(s) in Company
22nd Jan 20145:34 pmRNSExercise of Share Options
21st Jan 20144:06 pmRNSExercise of Share Options
17th Jan 20144:24 pmRNSDirector/PDMR Shareholding
15th Jan 20147:00 amRNSInterim Results
15th Jan 20147:00 amRNSAcquisition
15th Jan 20147:00 amRNSConclusion of Review of Strategic Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.